GNLX Stock Price, GENELUX CORPORATION Quote, Chart

Market Summary

USD3.67+0.07

Delayed

1.94%

GNLX Alerts

1 major insider sales recently.

GNLX Stock Price

View Fullscreen

GNLX RSI Chart

GNLX Valuation

Market Cap

99.1M

Price/Earnings (Trailing)

-3.84

Price/Sales (Trailing)

582.81

Price/Free Cashflow

-4.72

GNLX Price/Sales (Trailing)

GNLX Profitability

Return on Equity

-170.93%

Return on Assets

-104.49%

Free Cashflow Yield

-21.18%

GNLX Fundamentals

GNLX Revenue

Revenue (TTM)

170.0K

Rev. Growth (Yr)

-100%

Rev. Growth (Qtr)

-100%

GNLX Earnings

Earnings (TTM)

-25.8M

Earnings Growth (Yr)

24.26%

Earnings Growth (Qtr)

-16%

Breaking Down GNLX Revenue

Last 7 days

-4.2%

Last 30 days

1.4%

Last 90 days

-53.2%

How does GNLX drawdown profile look like?

GNLX Financial Health

Current Ratio

2.72

GNLX Investor Care

Shares Dilution (1Y)

9.45%

Diluted EPS (TTM)

-0.95

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	8.3M	5.6M	2.9M	170.0K
2022	0	0	0	11.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of GENELUX CORPORATION

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 08, 2024	szalay aladar	sold	-53,188	3.8213	-13,919	-
May 07, 2024	szalay aladar	sold	-22,111	3.6699	-6,025	-
May 01, 2024	szalay aladar	sold	-109,161	3.3018	-33,061	-
Apr 30, 2024	szalay aladar	sold	-63,980	3.1157	-20,535	-
Apr 29, 2024	szalay aladar	sold	-20,792	3.2473	-6,403	-
Apr 24, 2024	szalay aladar	sold	-28,250	3.5033	-8,064	-
Apr 23, 2024	szalay aladar	sold	-76,799	3.4909	-22,000	-
Apr 22, 2024	szalay aladar	sold	-50,597	3.5306	-14,331	-
Apr 17, 2024	szalay aladar	sold	-84,424	3.7131	-22,737	-
Apr 16, 2024	szalay aladar	sold	-171,802	3.529	-48,683	-

Which funds bought or sold GNLX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-37.2	-30,454	12,333	-%
May 15, 2024	Royal Bank of Canada	reduced	-51.47	-116,000	34,000	-%
May 15, 2024	DEUTSCHE BANK AG\	added	3.13	-50,425	45,319	-%
May 15, 2024	STATE STREET CORP	added	4.66	-2,748,030	2,539,950	-%
May 15, 2024	WELLINGTON MANAGEMENT GROUP LLP	sold off	-100	-360,996	-	-%
May 15, 2024	MORGAN STANLEY	reduced	-4.15	-485,803	381,543	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	added	102	-23,069	307,385	-%
May 15, 2024	BARCLAYS PLC	reduced	-47.27	-271,000	86,000	-%
May 15, 2024	OCCUDO QUANTITATIVE STRATEGIES LP	new	-	80,690	80,690	0.01%
May 15, 2024	Walleye Capital LLC	new	-	65,573	65,573	-%

Are Funds Buying or Selling GNLX?

Are funds buying GNLX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own GNLX

No. of Funds

GNLX Alerts

1 major insider sales recently.

Unveiling GENELUX CORPORATION's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 02, 2024	szalay aladar	15.7%	4,185,305	SC 13G

Recent SEC filings of GENELUX CORPORATION

View All Filings

Date Filed	Form Type	Document
May 15, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	10-Q	Quarterly Report
May 01, 2024	4	Insider Trading
Apr 24, 2024	4	Insider Trading
Apr 18, 2024	4	Insider Trading
Apr 15, 2024	144/A	144/A
Apr 11, 2024	144	Notice of Insider Sale Intent
Apr 09, 2024	8-K	Current Report
Apr 02, 2024	8-K	Current Report

Peers (Alternatives to GENELUX CORPORATION)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	234.45%	75.34%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

GENELUX CORPORATION News

Latest updates

GENELUX CORPORATION Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)							(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Revenue	-	-	-	2,200	4,400	6,600	8,800	11,000
Operating Expenses	16.0%	8,123	7,001	5,307	5,395	6,632	3,162	4,656
S&GA Expenses	-100.0%	-	2,841	2,488	2,452	3,787	694	2,242
R&D Expenses	-3.6%	4,010	4,160	2,819	2,943	2,845	2,468	2,414
Interest Expenses	-	-	-	22.00	-	50.00	40.00	39.00
Income Taxes	-	-	-	-	-	-	-	1,100
Earnings Before Taxes	-	-	-	-5,345	-	-	-	6,009
Net Income	-16.0%	-7,850	-6,767	-5,345	-5,821	-10,364	-3,495	4,909
Net Income Margin	8.9%	-151.66*	-166.45*	-8.65*	-2.63*	-1.41*	-0.47*	-
Free Cashflow	38.7%	-4,384	-7,153	-3,634	-5,814	-4,699	-1,518	-2,503

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet						(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Assets	-11.5%	24,676	27,893	34,072	31,363	14,616	5,531
Current Assets	-12.4%	21,204	24,203	31,179	28,683	12,056	1,892
Cash Equivalents	-56.9%	4,061	9,418	29,869	27,140	10,338	397
Net PPE	-4.6%	1,116	1,170	1,022	878	617	644
Liabilities	13.9%	9,592	8,420	10,044	9,107	11,925	41,314
Current Liabilities	19.1%	7,805	6,554	8,755	7,878	10,543	31,626
Long Term Debt	-	-	-	-	-	-	8,524
LT Debt, Non Current	-	-	-	-	-	-	8,524
Shareholder's Equity	-22.5%	15,084	19,473	24,028	22,256	2,691	-35,783
Retained Earnings	-3.5%	-229,374	-221,524	-214,757	-209,412	-203,591	-189,784
Additional Paid-In Capital	1.4%	244,869	241,389	239,189	232,073	206,688	154,401
Shares Outstanding	0.3%	26,865	26,789	26,658	25,856	24,553	9,127

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)									(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	37.0%	-4,354	-6,910	-3,357	-5,418	-4,590	-1,518	-2,470	-2,408	2,825
Share Based Compensation	-2.9%	1,489	1,533	515	240	227	43.00	1,703	297	372
Cashflow From Investing	87.9%	-1,691	-13,942	-277	-396	-109	-	-33.00	-1.00	-15.00
Cashflow From Financing	71.6%	688	401	6,363	22,616	14,640	545	-329	-564	-130

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

GNLX Income Statement

2024-03-31

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 8	$ 170
Operating expenses:
Research and development	4,010	2,845
General and administrative	4,113	3,787
Total operating expenses	8,123	6,632
Loss from operations	(8,115)	(6,462)
Other income (expenses):
Interest income	265
Interest expense		(143)
Debt discount amortization		(649)
Financing costs		(3,110)
Total other income (expenses), net	265	(3,902)
NET LOSS	$ (7,850)	$ (10,364)
LOSS PER COMMON SHARE - BASIC	$ (0.29)	$ (0.53)
LOSS PER COMMON SHARE - DILUTED	$ (0.29)	$ (0.53)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - BASIC	26,849,737	19,575,631
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - DILUTED	26,849,737	19,575,631

GNLX Balance Sheet

2024-03-31

Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 4,061	$ 9,418
Short-term investments	15,566	13,773
Prepaid expenses and other current assets	1,577	1,012
Total Current Assets	21,204	24,203
Property and equipment, net	1,116	1,170
Right of use assets	2,264	2,428
Other assets	92	92
Total Other Assets	3,472	3,690
TOTAL ASSETS	24,676	27,893
Current Liabilities
Accounts payable and accrued expenses	5,313	3,784
Accrued payroll and payroll taxes	1,908	2,117
Lease liabilities, current portion	584	653
Total Current Liabilities	7,805	6,554
Lease liabilities, long-term portion	1,787	1,866
Total Liabilities	9,592	8,420
Shareholders’ Equity
Preferred stock, par value $0.001, 10,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 200,000,000 shares authorized; 26,996,740 and 26,788,986 shares issued and outstanding, respectively	27	27
Treasury stock, 433,333 shares, at cost	(433)	(433)
Additional paid-in capital	244,869	241,389
Accumulated other comprehensive income (loss)	(5)	14
Accumulated deficit	(229,374)	(221,524)
Total Shareholders’ Equity	15,084	19,473
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 24,676	$ 27,893

About GENELUX CORPORATION

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

CEO	Mr. Thomas Zindrick J.D.
WEBSITE	genelux.com
INDUSTRY	Biotechnology
EMPLOYEES	20

GENELUX CORPORATION Frequently Asked Questions

What is the ticker symbol for GENELUX CORPORATION? What does GNLX stand for in stocks?

GNLX is the stock ticker symbol of GENELUX CORPORATION. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of GENELUX CORPORATION (GNLX)?

As of Fri May 17 2024, market cap of GENELUX CORPORATION is 99.08 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GNLX stock?

You can check GNLX's fair value in chart for subscribers.

What is the fair value of GNLX stock?

You can check GNLX's fair value in chart for subscribers. The fair value of GENELUX CORPORATION is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of GENELUX CORPORATION is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GNLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is GENELUX CORPORATION a good stock to buy?

The fair value guage provides a quick view whether GNLX is over valued or under valued. Whether GENELUX CORPORATION is cheap or expensive depends on the assumptions which impact GENELUX CORPORATION's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GNLX.

What is GENELUX CORPORATION's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, GNLX's PE ratio (Price to Earnings) is -3.84 and Price to Sales (PS) ratio is 582.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GNLX PE ratio will change depending on the future growth rate expectations of investors.